Brad Hively - Nov 17, 2023 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Brad Hively
Stock symbol
TOI
Transactions as of
Nov 17, 2023
Transactions value $
-$34,750
Form type
4
Date filed
11/21/2023, 07:27 PM
Previous filing
Nov 15, 2023
Next filing
Nov 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Options Exercise $21.3K +25K +3.59% $0.85 722K Nov 17, 2023 Direct
transaction TOI Common stock Sale -$56K -25K -3.46% $2.24 697K Nov 17, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOI Non-Qualified Stock Option (right to buy) Options Exercise $0 -25K -1.41% $0.00 1.75M Nov 17, 2023 Common stock 25K $0.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest monthly for 36 months following November 12, 2021, the date of the closing of the Business Combination.